Trial Profile
Long Term Immune Memory Responses to Human Papillomavirus (HPV) Vaccination Following 2 Verses 3 Doses of Quadrivalent HPV Vaccine
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Jun 2021
Price :
$35
*
At a glance
- Drugs Human papillomavirus vaccine recombinant quadrivalent Merck (Primary)
- Indications Human papillomavirus infections
- Focus Pharmacodynamics
- Acronyms Merck08
- 23 Jun 2021 Status changed from active, no longer recruiting to completed.
- 05 Apr 2021 According to ClinicalTrials.gov, the recruitment status of this study is unknown because the information has not been verified recently (last Verified April 2019 by Manish Sadarangani, University of British Columbia).
- 16 Apr 2019 Planned End Date changed from 1 May 2020 to 1 Dec 2020.